WHEA:SW:SW-SPDR MSCI World Health Care UCITS ETF (USD)

ETF | Others |

Last Closing

USD 59.83

Change

0.00 (0.00)%

Market Cap

N/A

Volume

1.25K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-26 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
RGLDS:SW Raiffeisen ETF Solid Gold A US..

+3.00 (+0.04%)

USD 134,034.93B
RGLDSH:SW Raiffeisen ETF Solid Gold H CH..

-12.00 (-0.25%)

USD 134,034.91B
RGLDOH:SW Raiffeisen ETF Solid Gold Ounc..

-4.20 (-0.28%)

USD 134,034.86B
RGLDO:SW Raiffeisen ETF Solid Gold Ounc..

-1.00 (-0.05%)

USD 134,034.85B
SX7EEX:SW iShares EURO STOXX Banks 30-15..

+0.10 (+0.71%)

USD 6,289.31B
TDXPEX:SW iShares TecDAX® UCITS ETF (DE..

-0.01 (-0.02%)

USD 5,933.97B
SMIEX:SW iShares SLI UCITS ETF (DE)

+0.80 (+0.61%)

USD 5,933.96B
DJSXE:SW iShares Core EURO STOXX 50 UCI..

N/A

USD 5,933.96B
DAXEX:SW iShares Core DAX® UCITS ETF (..

+0.90 (+0.60%)

USD 5,933.93B
MDAXEX:SW iShares MDAX® UCITS ETF (DE) ..

+0.75 (+0.35%)

USD 5,933.92B

ETFs Containing WHEA:SW

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.66% 41% F 44% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.66% 40% F 43% F
Trailing 12 Months  
Capital Gain 5.41% 43% F 47% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.41% 43% F 46% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 2.28% 54% F 54% F
Dividend Return 2.28% 54% F 54% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 4.57% 59% D- 64% D
Risk Adjusted Return 49.74% 56% F 60% D-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike